Stryker elects James E. Davis to its board, effective January 1, 2027

On November 3, 2026, Stryker's board increased the number of authorized directors from 11 to 12 and elected James E. Davis to fill the resulting vacancy. Stryker said Davis's election will become effective January 1, 2027.

Davis has chaired the Quest Diagnostics board since April 2023. He joined Quest in 2013 as senior vice president, diagnostic services, and was named senior vice president, operations in February 2014.

Before joining Quest, Davis was CEO of InSightec, Inc., a global medical device company. He spent two decades in senior management roles across General Electric's healthcare and aviation businesses, including five years leading GE's MRI business. Before GE, he led the development of strategic and operating initiatives for clients of McKinsey & Company, Inc.

Stryker said Davis has not been appointed to any committee of the board at this time. It said he will be compensated consistent with its other non-employee directors, as described in its proxy statement for its 2026 annual meeting of stockholders.

Kevin Lobo, Chair and CEO of Stryker, said Davis's healthcare experience, operational leadership and understanding of medical technology would add to the board as the company continues to advance its strategy and mission.